AVITA Medical, Inc. Announces Annual Meeting of Stockholders on June 5, 2024

TL;DR

<b>AVITA Medical, Inc. will host its annual stockholder meeting virtually on June 5, 2024, encouraging prompt voting.</b>

AI Summary

AVITA Medical, Inc. (AVHHL) filed a Proxy Statement (DEF 14A) with the SEC on April 23, 2024. AVITA Medical, Inc. will hold its annual meeting of stockholders on June 5, 2024, at 3:00 p.m. Pacific Daylight Time. The meeting will be conducted in a virtual format via a live audio webcast at meetnow.global/MKRAKJK. Stockholders will not be able to attend the meeting in person. The company is promoting the use of the internet for proxy materials to reduce costs and environmental impact. Stockholders are encouraged to vote their shares promptly.

Why It Matters

For investors and stakeholders tracking AVITA Medical, Inc., this filing contains several important signals. The shift to a virtual meeting format aims to increase stockholder access, improve communication, and reduce company costs and environmental impact. Encouraging prompt voting ensures that all eligible shares are represented and considered in the company's decision-making processes.

Risk Assessment

Risk Level: — AVITA Medical, Inc. shows moderate risk based on this filing. The filing is a routine proxy statement for an annual meeting, with no immediate financial or operational risks disclosed.

Analyst Insight

Review the proxy materials to understand the proposals being voted on and cast your vote before the June 5, 2024 meeting.

Key Numbers

• June 5, 2024 — Annual Meeting Date (Date of the annual meeting of stockholders)
• 3:00 p.m. PDT — Annual Meeting Time (Time of the annual meeting of stockholders)

Key Players & Entities

• AVITA Medical, Inc. (company) — Registrant name
• June 5, 2024 (date) — Date of annual meeting
• 3:00 p.m. Pacific Daylight Time (time) — Time of annual meeting
• June 6, 2024 (date) — Date of annual meeting in Australian time
• 8:00 a.m. Australian Eastern Standard Time (time) — Time of annual meeting in Australian time
• meetnow.global/MKRAKJK (url) — Link for virtual meeting webcast

FAQ

Industry Context

AVITA Medical, Inc. operates in the biotechnology and medical device sector, focusing on regenerative medicine solutions.

Regulatory Implications

The filing is a Schedule 14A (DEF 14A) under the Securities Exchange Act of 1934, requiring public companies to provide detailed information to shareholders for annual meetings.

What Investors Should Do

1. Review the proxy statement for details on proposals and voting procedures.
2. Register and attend the virtual annual meeting on June 5, 2024.
3. Submit your vote promptly, whether or not you plan to attend the virtual meeting.

Key Dates

• 2024-06-05: Annual Meeting of Stockholders — Key date for stockholder participation and voting.

Year-Over-Year Comparison

This filing is a Definitive Proxy Statement (DEF 14A) for the 2024 annual meeting, following the typical reporting requirements for such events.

Key Financial Figures

• $87,500 — tock ("Common Stock") equal in value to $87,500 (at the time of the grant) and the gran
• $37,500 — hares of Common Stock equal in value to $37,500 (at the time of the grant) to Mr. Lou P

Filing Documents

• rcel-20240423.htm (DEF 14A) — 1012KB
• img179645402_0.jpg (GRAPHIC) — 11KB
• img179645402_1.jpg (GRAPHIC) — 11KB
• img179645402_2.jpg (GRAPHIC) — 1434KB
• img179645402_3.jpg (GRAPHIC) — 723KB
• img179645402_4.jpg (GRAPHIC) — 523KB
• img179645402_5.jpg (GRAPHIC) — 554KB
• 0000950170-24-047056.txt (&nbsp;) — 9041KB
• rcel-20240423.xsd (EX-101.SCH) — 7KB
• rcel-20240423_htm.xml (XML) — 1KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS 17 INFORMATION ABOUT THE COMPANY'S EXECUTIVE OFFICERS 18 COMPENSATION AND OTHER INFORMATION CONCERNING THE COMPANY'S EXECUTIVE OFFICERS AND DIRECTORS 19 Summary Compensation Table 19 Employment Contracts 20 Compensation Principles 21 Outstanding Equity Awards at Fiscal Year End 22 Director Compensation 22 PROPOSALS 3 – 8 APPROVAL OF THE GRANT OF OPTIONS AND RESTRICTED STOCK UNITS TO NON-EXECUTIVE DIRECTORS 24 PROPOSAL 9 APPROVAL OF THE GRANT OF OPTIONS TO MR. JAMES CORBETT, CHIEF EXECUTIVE OFFICER OF THE COMPANY 33 PROPOSAL 10 ADVISORY VOTE TO APPROVE THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS 37 ANNUAL REPORT 38 REQUIREMENTS FOR STOCKHOLDER PROPOSALS TO BE BROUGHT BEFORE THE 2025 ANNUAL MEETING 38 CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS 39 DELINQUENT SECTION 16(a) REPORTS 39 WHERE YOU CAN FIND MORE INFORMATION 39 AVITA MEDICAL, INC. 28159 Avenue Stanford, Suite 220 Valencia, CA 91355 PROXY STATEMENT for ANNUAL MEETING OF STOCKHOLDERS to be held on June 5, 2024, at 3:00 p.m. Pacific Daylight Time (being June 6, 2024, at 8:00 a.m. Australian Eastern Standard Time) SOLICITATION OF PROXY The accompanying proxy is solicited on behalf of the board of directors (the "Board of Directors" or "Board") of the Company, for use at the annual meeting of stockholders (the "Annual Meeting") to be held on June 5, 2024, at 3:00 p.m. Pacific Daylight Time (being June 6, 2024, at 8:00 a.m. Australian Eastern Standard Time ("AEST")) by way of a virtual meeting conducted via live webcast at meetnow.global/MKRAKJK. This Proxy Statement contains information about the matters to be considered at the meeting or any adjournments or postponements of the meeting. The Company will bear the cost of solicitation of proxies. In addition to solicitation by mail, the Company's directors, officers

View Full Filing

View this DEF 14A filing on SEC EDGAR